Authors

Abiodun Emmanuel Akinwuntan, PhD, MPH

Latest:

Prediction of Driving Ability in People with Relapsing-Remitting Multiple Sclerosis Using the Stroke Driver Screening Assessment

Sarah F. Shelton, PsyD

Latest:

Psychological Consultation Services at a Multiple Sclerosis Clinic

Tamara McKenzie, PsyD

Latest:

Care Partners and Multiple Sclerosis

Gertraud Stadler, PhD

Latest:

An Exploratory Investigation of Social Stigma and Concealment in Patients with Multiple Sclerosis

Vanessa Bouchard, MSc

Latest:

Development of a Bilingual MS-Specific Health Classification System

Petra Skeffington, PhD

Latest:

Disaster Preparation for People With Multiple Sclerosis: A Scoping Review of Resources

Disaster events disproportionally affect persons with disabilities; as there is an increasing likelihood of disasters globally, clinicians should consider identifying resources to prepare patients for disasters.

Lynn M. Clement, MPH

Latest:

Factors Associated with Health-Related Quality of Life Among Older People with Multiple Sclerosis

Kristin Reindel, PharmD

Latest:

Pneumococcal Vaccination Practices in Patients With Multiple Sclerosis Receiving Anti-CD20 Monoclonal Antibodies After Pharmacy and Nursing Collaboration

Maria Lucas, BA

Latest:

Preferences for Multiple Sclerosis Treatments

Tessa M. Watson, DClinPsy

Latest:

Validation of Mood Measures for People with Multiple Sclerosis

J. Keiko McCreary, PhD

Latest:

Upper Limb Intention Tremor in Multiple Sclerosis

Jennie Q. Lou, MD, MSc, OTR

Latest:

Exploring Rehabilitation and Wellness Needs of People with MS Living in South Florida: A Pilot Study

Denise Globe, PhD

Latest:

Development and Validation of the Actionable Bladder Symptom Screening Tool for Multiple Sclerosis Patients

Edward Monaghan, PhD

Latest:

Enrollment in a Multiple Sclerosis Clinical Trial: The EVIDENCE Experience

Ragaa Ibrahim, PhD

Latest:

Alternative Medicine and Multiple Sclerosis: An Objective Review from an American Perspective

Daryl Kucera, ACE

Latest:

Impact of Resistance Training on Balance and Gait in Multiple Sclerosis

Sylvia Lucas, MD, PhD

Latest:

Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab

Philip J. Aliotta, MD, MSHA, CHCQM, FACS

Latest:

A Framework of Care in Multiple Sclerosis, Part 2

Teresa Ostler, PhD

Latest:

Perspectives on Physical Activity Among People with Multiple Sclerosis Who Are Wheelchair Users

Bryan D. Walker, MHS, PA-C

Latest:

A Framework of Care in Multiple Sclerosis, Part 2

Audra Boscoe, PhD

Latest:

Assessment of Patients with Neuromyelitis Optica Spectrum Disorder Using the EQ-5D

James B. Lewin, PharmD

Latest:

Characterizing Long-term Disability Progression and Employment in NARCOMS Registry Participants with Multiple Sclerosis Taking Dimethyl Fumarate

John D. Scott, MD

Latest:

Impact of Multiple Sclerosis Project ECHO (Extension for Community Healthcare Outcomes) on Provider Confidence and Clinical Practice

Magdalena Wojtowicz, HBSc

Latest:

Intra-individual Variability as a Measure of Information Processing Difficulties in Multiple Sclerosis

Mozaffar Hosseininezhad, MD

Latest:

The Multiple Sclerosis Self-Management Scale–Revised (MSSM-R)

Seema Rani Khurana, DO

Latest:

Effect of Cognitive Demand on Functional Mobility in Ambulatory Individuals with Multiple Sclerosis

David Bates, MA

Latest:

Development and Validation of the Actionable Bladder Symptom Screening Tool for Multiple Sclerosis Patients

Daphne Kos, PhD

Latest:

Designing Well-Being Intervention Trials for People With Progressive Multiple Sclerosis: The Importance of Understanding Usual Care Comparators

For a clinical audience, our team’s efforts highlight that usual care looks different across clinics, regions, and countries, which highlights the importance of interpreting the results of trials with usual care comparators carefully.

Karin Mente, MD

Latest:

Triaging Patients with Multiple Sclerosis in the Emergency Department

Jonathan Calkwood, MD

Latest:

Safety and Tolerability of Delayed-Release Dimethyl Fumarate Administered with Interferon Beta or Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis

<1
...
484950515253545556
...
102>